Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia (Quit4Life+ )

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug, Behavioral
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

This proposal tests the efficacy of a phone-based tobacco cessation intervention for people living with HIV (PLWH) in comparison to the standard of care (brief advice to quit) and nicotine replacement therapy (nicotine patches) in Uganda and Zambia. This study will provide insight into the efficacy, feasibility, applicability, and affordability of delivering tobacco cessation interventions through health care professionals at HIV treatment centers in two countries with different tobacco use patterns, policy environments, and health care resources. The previously tested SMS-platform to be used in this study is uniquely positioned to be scaled in low- and middle-income countries worldwide, in which case rigorous research showing even modest success in reducing the prevalence of tobacco consumption among PLWH could confer substantial health and economic benefits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• \-

Locations
Other Locations
Uganda
Makerere University
RECRUITING
Kampala
Zambia
University of Zambia
RECRUITING
Lusaka
Time Frame
Start Date: 2023-09-13
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 800
Treatments
No_intervention: Standard of Care
This is the baseline group receiving advice to quit.
Active_comparator: Nicotine Replacement
This group will receive the standard of care and be prescribed nicotine replacement therapy
Active_comparator: Text Messaging
This group will receive the standard of care and receive text message support
Active_comparator: Nicotine replacement and text messaging
This group will receive the standard of care, be prescribed nicotine replacement therapy, and receive text message support
Related Therapeutic Areas
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov